Skip to main content

Nonprofit · EIN 31-1340154

OHIO HEMATOPOIETIC TRANSPLANT AND CELLULAR THERAPY CONSORTIUM

Tax-exempt · GALENA, OH 43021

Financials

$99K$131K2023$88K$104K2024$157K$100K2025
Revenue Expenses · by fiscal year end
Financials of OHIO HEMATOPOIETIC TRANSPLANT AND CELLULAR THERAPY CONSORTIUM by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2025990$157,392$99,855$57,537$358,933$99,804$259,129
December 31, 2024990$87,563$104,399-$16,836$333,846$132,254$201,592
December 31, 2023990$99,377$131,258-$31,881$315,778$97,350$218,428
Financial details: 990 for the year ended December 31, 2025

Revenue

Contributions, gifts and grants
$0
Program service revenue
$157,350
Investment income
$42
Other revenue
$0

Expenses

Grants and similar amounts paid
$0
Salaries, compensation and benefits (total)
$0
Professional fundraising fees
$0
Accounting fees
$2,300
Program services (functional)
$92,217
Management and general (functional)
$7,638

Balance sheet and other

Total assets, start of year
$333,846
Total assets, end of year
$358,933
Total liabilities, end of year
$99,804
Net assets, end of year
$259,129
Gross receipts
$157,392
Employees
0
Volunteers
0
Year formed
1992
State of legal domicile
OH

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2025, highest compensation first.

NameTitleHours / weekCompensation
MATT KALAYCIOBOARD CHAIRMAN
Trustee or director
1$0
BERNI MCQUIGGBOARD TREASURER
Trustee or director
1$0
STEVEN KUERBITZ MDBOARD MEMBER
Trustee or director
1$0
JEFFREY AULETTABOARD MEMBER
Trustee or director
1$0
JAMES ESSELL MDBOARD MEMBER
Trustee or director
1$0
DONNA STURGILLDIRECTOR
Trustee or director
2$0
990 for the year ended December 31, 2024: 6 people
NameTitleHours / weekCompensation
MATT KALAYCIOBOARD CHAIRMAN
Trustee or director
1$0
BERNI MCQUIGGBOARD TREASURER
Trustee or director
1$0
STEVEN KUERBITZ MDBOARD MEMBER
Trustee or director
1$0
JEFFREY AULETTABOARD MEMBER
Trustee or director
1$0
JAMES ESSELL MDBOARD MEMBER
Trustee or director
1$0
DONNA STURGILLDIRECTOR
Trustee or director
2$0
990 for the year ended December 31, 2023: 5 people
NameTitleHours / weekCompensation
JEFFREY AULETTABOARD MEMBER
Trustee or director
–$0
MATT KALAYCIOBOARD CHAIRM
Trustee or director
–$0
BERNI MCQUIGGBOARD TREASU
Trustee or director
–$0
JAMES ESSELL MDBOARD MEMBER
Trustee or director
–$0
STEVEN KUERBITZ MDBOARD MEMBER
Trustee or director
–$0

Address and contacts

Address (IRS master file)
5400 PORT HAVEN DR, GALENA, OH 43021-8902
In care of
% AUDREY BOHNENGEL
Principal officer (990 for 2025)
MATT KALAYCIO, 5400 PORT HAVEN DRIVE, GALENA, OH 43021
Signed the 990
MATT KALAYCIO, BOARD CHAIRMAN
Phone
(440) 715-3078
Return prepared by
PRP & ASSOCIATES

Mission

TO ENSURE ALL OHIO RESIDENTS HAVE ACCESS TO QUALITY CARE FOR HEMATOLOGIC MALIGNANCIES.

990 for the year ended December 31, 2025

Program accomplishments

  • IDENTIFYING PATIENTS FOR TRANSPLANT BASED ON PATIENT SELECTION CRITERIA AND CLINICAL SUMMARIES. PROVIDING ACCESS INFORMATION AND MAINTAINING A STATE WIDE WAITING LIST.
  • PROFESSIONAL/PUBLIC EDUCATION-PROVIDING INFORMATION TO PUBLIC AND INSURERS ABOUT CONSORTIUM, INDICATIONS FOR HSCT, AND STANDARDS FOR CARE.
  • QUALITY ASSURANCE/PROGRAM REVIEW - DEVELOPING STANDARDS FOR REVIEWING PATIENT SUMMARIES AND HSCT PROGRAMS.
    Expenses $92,217 · revenue $157,350

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026990 on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
31-1340154
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
1992
Accounting year ends
December
Files
Form 990 or 990-EZ
Assets (IRS master file)
$358,933
Income (IRS master file)
$157,392

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2025$157,392$99,855$358,933XML
990December 2024$87,563$104,399$333,846IRS
990December 2023$99,377$131,258$315,778XML
990December 2022$105,149$82,574$330,785IRS
990December 2021–––IRS
990December 2020–––IRS
990December 2019–––IRS
990December 2018–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 31-1340154).

Questions about OHIO HEMATOPOIETIC TRANSPLANT AND CELLULAR THERAPY CONSORTIUM

What is the EIN of OHIO HEMATOPOIETIC TRANSPLANT AND CELLULAR THERAPY CONSORTIUM?
The employer identification number (EIN) of OHIO HEMATOPOIETIC TRANSPLANT AND CELLULAR THERAPY CONSORTIUM is 31-1340154.
Is OHIO HEMATOPOIETIC TRANSPLANT AND CELLULAR THERAPY CONSORTIUM tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1992.
Are donations to OHIO HEMATOPOIETIC TRANSPLANT AND CELLULAR THERAPY CONSORTIUM tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does OHIO HEMATOPOIETIC TRANSPLANT AND CELLULAR THERAPY CONSORTIUM file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of OHIO HEMATOPOIETIC TRANSPLANT AND CELLULAR THERAPY CONSORTIUM due?
The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
When did OHIO HEMATOPOIETIC TRANSPLANT AND CELLULAR THERAPY CONSORTIUM last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2025.
Who is the principal officer of OHIO HEMATOPOIETIC TRANSPLANT AND CELLULAR THERAPY CONSORTIUM?
The 990 for the year ended December 31, 2025 names MATT KALAYCIO.
Who are the officers and directors of OHIO HEMATOPOIETIC TRANSPLANT AND CELLULAR THERAPY CONSORTIUM?
The 990 for the year ended December 31, 2025 lists 6 people; 0 received compensation from the organization.
How much revenue does OHIO HEMATOPOIETIC TRANSPLANT AND CELLULAR THERAPY CONSORTIUM have?
On its 990 for the year ended December 31, 2025 it reported revenue of $157,392, expenses of $99,855 and total assets of $358,933 at year end.

Other nonprofits in GALENA

All nonprofits in GALENA · Ohio · Voluntary health associations and medical disciplines